Lyka Labs Reports Strong Half-Year Sales Growth Amid Liquidity Challenges

Lyka Labs, a microcap player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending December 2024. The evaluation changes reflect a notable shift in the company's score, which has adjusted from 23 to 16 over the past three months.
The financial data reveals several positive trends for Lyka Labs. The company achieved net sales of Rs 74.96 crore for the half-yearly period, marking a year-on-year growth of 23.80%. Additionally, the profit after tax (PAT) reached Rs 2.71 crore in the latest quarter, representing the highest figure recorded in the last five quarters. This trend indicates a strengthening in profitability, as evidenced by the earnings per share (EPS) of Rs 0.76, also the highest in the same timeframe.

Conversely, the financial results highlight challenges as well. The cash and cash equivalents have fallen to Rs 1.11 crore, the lowest level observed in the last six half-yearly periods, suggesting a decline in short-term liquidity.

For more insights on Lyka Labs and its financial performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.